Preprint
Review

Redox Signaling in Endosomes on the Example of EGF Receptors

Altmetrics

Downloads

66

Views

22

Comments

0

A peer-reviewed article of this preprint also exists.

This version is not peer-reviewed

Submitted:

24 September 2024

Posted:

25 September 2024

You are already at the latest version

Alerts
Abstract
Early Endosomes represent first line sorting compartments or even organelles for internalized molecules. They enable the transport of molecules or ligands to other compartments of the cell, such as lysosomes for degradation or recycle them back to the membrane by various mechanisms. Moreover, early endosomes function as signaling and scaffolding platform to initiate or prolong distinct signaling pathways. Accordingly, early endosomes have to be recognized as either part of a degradation or recycling pathway. The physical proximity of many ligand-binding receptors with other membrane bound proteins or complexes such as NADPH oxidases may result in an interaction of second messengers like reactive oxygen species (ROS) and early endosomes that promote correct recognition of individual early endosomes. In fact, redoxosomes comprise an endosomal subsection of signaling endosomes. One example of such potential interaction is epidermal growth factor receptor (EGFR) signaling. Here we summarize recent findings on EGFR signaling as a well-studied example for receptor trafficking and trans-activation and illustrating the interplay between cellular and endosomal ROS.
Keywords: 
Subject: Biology and Life Sciences  -   Biochemistry and Molecular Biology

1. Introduction

The plasma membrane of a cell is a highly dynamic structure with a permanent constitutive turnover, mainly facilitated by endosomes. For example, macrophages and fibroblasts internalize more than 200% of their entire surface area per hour [1]. A major task of the cellular membrane is to keep contact to the surrounding cells and tissue. In order to maintain environmental contact, cells express receptors at their surface to measure mechanical distortions or pressure to sense circumstances such as pH or temperature and eventually get information or instructions in a ligand mediated way. Those ligands usually find a specialized receptor and binding of both results in specific signaling pathway. Receptor mediated signaling is classified as listed in Table 1.
In this review, we will concentrate on type III signaling on the example of epithelial growth factor (EGF) and its receptor (epithelial growth factor receptor, EGFR), which involves receptor internalization.
Early endosomes are part of the endocytic trafficking pathways for cargo molecules internalized from the plasma membrane [2]. Internalization is carried out by diverse mechanisms including clathrin-dependent endocytosis, phago- and pinocytosis or routes utilizing dynamin, caveolae and other [3]. In all cases, early endosomes serve as the primary sorting platform for diverse cargo, for example receptors and their ligands [4,5,6].
The intention of this graphical review is to provide an overview of early endosomes in particular of key signaling components. In particular, we will address the endosomal sorting and trafficking of EGFR. Eventually, we will delineate the concept of redox-active endosomes (redoxosomes) using the example of EGFR trans-activation by endosomal reactive oxygen species (ROS).

1.1. Models of the Early Endosome

For the description of endocytic traffic (Figure 1), two basic models have been evolved, namely the “pre-existing compartment model” in contrast to the “maturation model” which are both disputed [7,8]. Briefly, the “pre-existing compartment model” aka “Endosomal carrier vesicle hypothesis” states constant endosomal compartments e.g. early endosomes and late with stable marker proteins. Consequently, cargo is shuttled through transport vesicles [8]. Conversely, in the “maturation model” a single structure gradually transforms into a functional different entity. In the latter case, regulatory proteins are rather recruited from the cytoplasm than resident at the endosome [6,9]. Both models agree on initial fusion events between primary endocytic vesicles and early endosomes followed by cargo sorting, but differ in the origin of later endosomal structures and their identity over time [7].

1.2. Structure of the Early Endosome

Early endosomes are dynamic and morphologically complex structures (Figure 2) displaying a cis-trans polarity. On the cis-side incoming vesicles are received, whereas the trans-side shows both tubular (~60 nm diameter, pH~6.5) and multivesicular (~300 nm diameter, pH~6.3-6.8) regions as functional subdomains [2]. Cargo molecules are sorted in the early endosomes either to degrading or recycling routes; however, in most cases the sorting signals are poorly understood [6].
Functional areas within early endosomes are likely organized by membrane-binding proteins like annexins interacting as well with the actin cytoskeleton and cholesterol-enriched rafts. Apart from shuttling vesicles budded of from the early endosomes, motor protein complexes including myosins, kinesins and dynein, control early endosomes’ intracellular movement [4,5].
In spite of the challenges to identify unique molecular markers for each endosomal component, Ras-associated proteins (Rab) and their effectors are essential in regulating endocytic traffic. In the early endosomes, especially Rab4,5,10,14,21,22 are prominent [5]. In the following section, we will exemplarily consider some key effectors of Rab4 and Rab5, although an exhaustive analysis of the complete signaling network at the early endosomes is beyond the scope of this review.

1.3. Signaling Pathways at Early Endosomes

As mentioned above, Rab proteins are involved in all aspects of vesicle processing (budding, fusion, tethering etc.) (Figure 2). In their active GTP-bound form, Rabs recruit specific effector proteins. Rab5-GTP promotes its own activation through a positive feedback circuit with Rab GTPase-binding effector protein 1 (Rabaptin-5) and Rab5 GDP/GTP exchange factor 5 (Rabex-5). Additionally, Rabaptin-5 plays a role in vesicle budding from the early endosomes by interacting with the clathrin adapter AP-1 [4].
Among the Rab5 effectors in early endosomes, the early endosomal antigen-1 (EEA1) is commonly used as an early endosomes marker [10]. EEA1 and Rab5 also participate in redoxosomes discussed in a later section of this review. In concert with soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), EEA1 mediates endosome fusions. Furthermore, EEA1 binds to phosphatidylinositol-3-phosphate (PtdIns3P) synthesized by phosphatidylinositol 3-kinase Vps34 complex [4]. In general, spatially restricted lipid synthesis and enrichment allow the selective recruitment of PtdIns3P-binding proteins like the NADPH oxidase subunit p40phox [2]. Similarly, PtdIns3P is converted to phosphatidylinositol-3,5-bisphosphate (PtdIns3,5P2) by the 1-phosphatidylinositol 3-phosphate 5-kinase (PIKFyve) complex. PIKFyve and its counterpart, the lipid phosphatase myotubularin (MTM1) tightly control PtdIns3P levels being crucial for proper EGFR sorting (see later section) [6]. Contrary to Rab5, Rab4 is not only localized on early endosomes but also on RE, in the first scenario Rab4 and Eps15 homology domain (EHD) proteins coordinate the exit of cargo to the perinuclear endocytic recycling compartment (ERC), which is part of the “slow-recycling” pathway in contrast to the “short loop” transport directly back to the plasma membrane [5]. Rab4 and Rab5 are linked by dual effectors e.g. Rab Interacting Protein 4 (RabIP4) and Rabenosyn-5 [2].
Although cargo sorting will not be covered in detail here, notably, the multiple subdomains inside the early endosomes permit cargo sorting to various organelles inter alia the trans-Golgi network. In this context, the multimeric retrograde transport machinery is initiated at the early endosomes through the action of sorting nexins (SNX) with other components of the retromer[5].
Interestingly, Rab effectors may partake in signal transduction as well, as it was shown for adapter protein containing PH domain, PTB domain and leucine zipper motif 1,2 (APPL1,2) which remodel nucleosomes and regulate the activity of the kinase Akt [4,11].
A growing body of evidence links early endosomes to signal transduction of internalized receptors. Internalization routes, ligand type and concentration determine the signaling outcome. In addition, signaling after endocytosis can be different to the plasma membrane depending on the specific protein equipment of the endosome [10].

2. The Endosomal Compartment in EGF Signaling

Binding of a ligand to type III receptors triggers internalization and recycling of the receptor itself as well as surrounding portions of the membrane. Internalization of the receptor represents a mechanism to control the dynamic of EGF signaling, as internalization of the EGFR and therefore reduction of the number of receptors at the cells surface at least transiently reduces the ability of its ligand EGF to spur further signaling [12].
Internalization of EGFR is stimulated after ligand-binding and trans-phosphorylation of the receptor tyrosine kinases [13]. We will not describe the mechanisms of EGFR activation and the downstream signaling cascades in this review, despite it should be noted that some EGFR-signaling is supposed not only be continued in early endosomes, but also several pathways seem to rely on endocytosis [11,14].
Internalization requires fusion of membrane cargo vesicles to organelles called endosomes (Figure 3). Those can be classified as early-, sorting-, recycling- or late endosomes depending on their stage of maturation [15,16], eventually lysosomes are considered to be part of the endosomal compartment [17]. As such early endosomes function as signaling and scaffolding platform to initiate or prolong distinct signaling pathways, or degradation of the internalized ligand and receptor. Accordingly, recognition of early endosomes as part of a degradation, signaling or recycling pathway represents a major step in ligand induced signal transduction.
Endocytosis involves or even depends on the GTPase dynamin 2, which forms helical polymers at lipid rafts at the necks of budding vesicles and its GTP hydrolysis-dependent conformational changes promote fission of the tubular membrane in order to generate a free endocytic vesicle [18]. According to the various nature of lipid rafts, two major models of endosome formation are proposed: Clathrin-dependent and -independent endocytosis. Clathrin-dependent endocytosis most often is described to build vesicles from 100–200 nm, while clathrin independent endocytosis is mediated by caveolins (caveolae) and lipid rafts, and involves smaller vesicles (40–80 nm) [17]. In case of EGFR (Figure 4.1), endocytosis is primarily clathrin-dependent and around 20-25% of clathrin coated pits are loaded with EGF at 37°C, no matter how high an EGF concentration is [19]. In fact, in different strains of human fibroblasts each cell contains 40,000-100,000 binding sites for EGF [12]. The data indicates a saturated internalization of EGF determined by the number of EGF binding sites. Interestingly, EGF loaded vesicles lose their clathrin coat as a prerequisite for further sorting and signaling. In general, internalized ligand-receptor complexes after endocytosis via clathrin-coated pits enter the endosomal compartment. EGFR endocytosis is subject to controversy concerning the conditions and proteins involved, anyways, studies suggest that EGFR is internalized via clathrin-dependent and independent pathways [14,20]. Besides, the dimerization partners influence the sensitivity to downregulation [21].
Once in early endosomes membrane proteins are rapidly recycled to the plasma membrane while fluid-phase proteins usually proceed towards the lysosome (Figure 4) [22].
A major peculiarity of early endosomes is their ability to facilitate recycling of non-ubiquitinated endocytosed receptors, while ubiquitinated receptors proceed to lysosomal degradation. Recycling endosomes are concentrated at the microtubule organizing center and consist of a largely tubular network [13]. While late endosomes are mainly spherical, lack tubules, and contain many closely packed intraluminal vesicles, early endosomes consist of a dynamic tubular-vesicular network with vesicles up to 1 µm in diameter and with connected tubules of approx. 50 nm diameter. For maturation of early endosomes into late endosomes, they become increasingly acidic (pH ≈ 6.0–6.8) maintained by an ATP-driven proton pump [23] or anion transporter chloride channels such as CLC3 [24], which results in the dissociation of the ligand from its receptor. Sorting of endosomes is mediated by Rab GTPases with Rab5 mainly expressed in early endosomes. Other Rab family members, Rab4 and Rab11 facilitate labelling of early endosomes as they generate recycling vesicles that fuse with plasma membrane, returning mostly non-ubiquitinated receptors directly back to cell surface. In contrast, Rab11-positive but Rab4-negative pericentriolar recycling endosomes appear to be important for membrane domain maintenance and membrane protein mobilization [25]. Within early endosomes, most receptors disengage from their ligands with subsequent recycling of the receptor and degradation of the ligand. In case of EGFR, disengagement is determined by the ligand bound. TGFα/EGFR is disengaged at endosomal pH, while EGF/EGFR is not. Different to LDL-receptors, EGF and the EGF receptor have a pH-resistant bond that persists until it is delivered to lysosomes for their degradation [26,27]. In both cases, adapter proteins like growth factor receptor-bound protein 2 (Grb2) and SH3 domain-containing kinase-binding protein 1 (CIN85) associate with the activated EGFR, leading to recruitment of the E3 ubiquitin (ub) ligase Cbl [28]. Next, Ub-binding proteins, for example of the clathrin coat, tether to Ub- chains at EGFR. In early endosomes, Cbl proceeds with EGFR ubiquitination, however the exact role for ubiquitination in EGFR endocytosis is not fully elucidated [29]. Even though many adapter proteins (Figure 4.1) like Epidermal growth factor receptor substrate 15 (Eps15, found in clathrin-coated pits), have shown to be important for EGFR endocytosis [30], the molecular mechanisms behind wait to become fully enlightened [14,20].
Unoccupied receptor then is quickly recycled back to the membrane, while ligand-bound receptor recycles only slowly or degrades in lysosomes. Sorting into Rab4,35 or Rab8,11 positive early endosomes domains promotes fast or slow recycling (cf. section above) accompanied by continuous deubiquitination (Figure 4.2). On the other side, if ubiquitinated EGFR is recognized by Rabex-5, hepatocyte growth-factor regulated tyrosine kinase substrate (Hrs) and tumor susceptibility gene 101 (Tsg101), EGFR degradation occurs (Figure 4.3). Hrs and signal transducing adapter molecule (STAM) cling EGFR in early endosomes, subsequently the whole ESCRT 0-III complexes assemble. Deubiquitinating enzymes (DUBs) remove Ub before EGFR sorting is completed to replenish the free Ub pool. Remarkably, apart from inactivating EGFR, protein tyrosine phosphatase PTP1B co-localizes with the receptor during the endocytic traffic, herby PTP1B dephosphorylates ESCRT members to foster lysosomal degradation [6,14]. Recently, autophagy has been shown to regulate EGFR trafficking from early endosomes and Rab11-mediated recycling [31].
Although initiation of the receptor endocytosis requires the cytoplasmic tail to be present, the process of endosomal retention and progression is independent from intrinsic receptor kinase activity. While in steady state 2-3% of all empty EGFR are internalized per minute, ligand binding accelerated internalization rates and retention of EGF/EGFR within the cell [32]. Internalized EGF/EGFR proceeds towards lysosomal degradation by maturation of early endosomes. While Rab5 is a component of early endosomes, Rab7 defines the functional identity of late endosomes and makes the compartment competent for fusion with lysosome (degradation competent) [33]. Accordingly, maturation of early endosome not only includes increasing acidification but also the so-called Rab5–Rab7 conversion. About 35% of Rab5-positive endosomes can be categorized as rapidly maturing, as they accumulate Rab7 with a time constant of 30 seconds, while the remaining 65% mature much slower, not acquiring Rab7 even after 100 seconds [19]. It is likely that the increase in Rab7 content arises from fusion with preexisting vesicles. EGF is preferentially targeted directly to the dynamic, rapidly maturing population of early endosomes (86%) with only a small fraction (14%) joining the static, slowly maturing endosomes. In contrast, the iron transporter transferrin undergoes none-selective sorting by early endosomes: Since the static, slowly maturing endosomes constitute a larger population than the dynamic, rapidly maturing ones, most of the transferrin molecules are delivered to the static population [19].
Clinically relevant are EGFR mutants displaying trafficking defects, thereby gaining oncogenic functions. Prominent examples comprise the variants EGFRvIV, EGFRvV, EGFRvIII, and v-ErbB which are supposed to be deficient in endocytic downregulation [20].

3. Redox Control of the Endosomal Compartment in EGF Signaling

At least a portion of endosomes baring clathrin coats can be sub-grouped into receptosomes (Figure 1) which enable further signaling of the appropriate receptors upon ligand binding [34]. Formation of receptosome selectively avoids fusion with lysosomes and thereby further degradation of receptors and ligands. An experiment published in 1996 may shed light on a possible redox mediated sorting procedure of EGF/EGFR complexes. For internalization, uncoated endocytic vesicles fuse with early endosomes as the first line of internalization. After emergence from these vacuoles, EGF/EGFR complexes are delivered exclusively to a preexisting subset of endocytic vacuoles, identified by fluid-phase horseradish peroxidases (HRP) internalized several hours before. Delivery of EGF to these preloaded vacuoles was inhibited by incubating living cells with DAB and H2O2. Consequently, EGF degradation was inhibited and late endosomes accumulated, while internalization of EGF proceeded with unaltered kinetics. In contrast, both, internalization and recycling of transferrin, which served as a control was unaffected [35]. Although we do not know what concentration was used in that study, it cannot be excluded that H2O2 had an effect on endosomal fusion. Lysosomes are characterized by markers such as lysosomal-associated membrane protein 1 (LAMP1) and mannose-6-phosphate receptor [11]. Interestingly, in the paper mentioned above, HRP-loaded vesicles are only positive for LAMP1, indicating, that vesicles arising from endocytosis do not express, but rather fuse to preformed vesicles containing mannose-6-phosphate receptor. The authors compared EGF- and transferrin-internalization in HEp-2 cells. While EGF-loaded late endosomes fused with HRP-preloaded lysosomes, transferrin-loaded vesicles did not [35]. Together these data underscore the possibility that EGF/EGFR-loaded late endosomes are distinct from transferrin-loaded late endosomes. Transferrin-loaded late endosomes may mature into lysosomes without fusion or fuse only to lysosomes positive for mannose-6-phosphate receptor, while EGF/EGFR-loaded late endosomes fuse with pre-existing lysosomes negative for mannose-6-phosphate receptor that arise from earlier endocytosis. In the context of redox signaling, it is important to note that a FRET probe based analysis of the human transferrin receptor 1 mediated endocytosis, attested a reducing environment in the endosomal compartments and the dynamics of transferrin receptor 1 trafficking [36].
In contrast, a group of specialized components of the endosomal compartment, termed “redoxosomes” are characterized by redox-active signaling, contain internalized, ligand-bound receptors that need reactive oxygen species (ROS) for signal transduction (Figure 5) [37]. The most prominent effector of ROS signaling are cysteines and disulfide bridges within proteins [38]. It is likely that lysosomes store hydrolases, potentially in an inactive form. Once a substrate has entered a lysosome, the proteolytic steps are probably performed by cysteine endoproteinases [39]. Reduction of disulfide bonds was discovered as a key step in increasing the access of proteolytic processing enzymes to target proteins in lysosomes. Accordingly, lysosomes where thought to be the vesicular compartment that mediates protein disulfide reduction, while it was clear by 1991 that early, recycling endosomes do not comprise reducing activity [40]. Later in 2005, Austin et al. found that recycling endosomes, late endosomes, and lysosomes are not reducing, but oxidizing and comparable with conditions in the endoplasmic reticulum [41]. These data indicate the existence of two distinct pathways within the endosomal compartment. One of which might be redox independent, while the other one depends on intra-endosomal ROS formation.

3.1. Redoxosomes

By nature, endosomes contain at least a portion of cell membrane and its ROS forming enzymes (Figure 5), internalized together with the receptor [42]. The major source of membrane associated ROS is the family of NADPH oxidases, which at present includes seven members (Nox1-5 as well as DUOX1 and 2) [43]. Especially Nox1 and Nox2 together with their associated subunits, p22phox for both, and NoxO1 and NoxA1 for Nox1, and p47phox and p67phox for Nox2, have been shown to act on redoxosomes [44,45]. Both, Nox1 and Nox2, produce •O2ˉ [46]. Nox2, the phagocytic NADPH oxidase, usually is recognized in endosomes and lysosomes within the process of unspecific host defense and antigen processing [47,48]. However, in SKOV3 cells treated with lysophosphatidic acid (LPA), internalization of the LPA receptor goes along with recruitment of Nox2 into early endosomes and subsequent LPA mediated signaling is abrogated when Nox2 activity is inhibited [49]. Further, Nox2 derived ROS where described to promote the formation of an active interleukin-1/MyD88 complex in endosomes of MCF-7 cells [50]. Obviously, endosomes containing Nox2 are composed of internalized plasma membrane and generate •O2ˉ into the endosomal lumen to initiate signaling at intracellular sites [51]. A potential mechanism of how the accompanying shift in endosomal charge is prevented was shown in human and murine aortic SMCs. Stimulation of those cells with tumor necrosis factor-alpha and interleukin-1 beta resulted in Nox1 and p22phox dependent ROS production within intracellular vesicles. ClC3 co-localizes with Nox1 in early endosomes and is required for charge neutralization of the electron flow generated by Nox1 across the membrane of signaling endosomes by transporting Clˉ and H+ (Figure 5.2). The importance of this mechanism is certified by the fact that cytokine activation of nuclear factor kappa B in SMCs requires both, Nox1 and ClC3 [52].
As pointed out above, H2O2 is the molecule needed to enable endosomal signaling. Accordingly, endosomes require spontaneous or enzyme-catalyzed dismutation of •O2ˉ into H2O2. Indeed, in addition to intra-endosomal localization of cytosolic SOD1, extracellular superoxide dismutase (ecSOD/ SOD3) is internalized in BSA stimulated murine endothelial cells and co-localizes with early endosome antigen EEA1 [53]. Interestingly, pH changes in the course of endosome progression may provide a feedback mechanism of SOD activity: Reduction of pH to or below 5 in late endosomes forces evasion of SOD1 from endosomes in human endothelial cells [54]. Although it is likely that changes in pH also affects endosomal localization of NADPH oxidases, it remains elusive, whether or not they determine processing of early endosomes. NADPH oxidase Nox4 directly produces H2O2 and therefore Nox4 mediated signaling is independent from SOD. As Nox4 is mainly expressed in the ER [55], it is likely that Nox4 stems from intracellular structures fused with early endosomes and accordingly may play a role in late endosomal signaling. In contrast activation of cluster of differentiation (CD)38 in early endosomes appears to be Nox4 dependent [56]. More research is needed to define the role of Nox4 in endosomal transition and signaling.

3.2. Redox-Dependent EGFR Trans-Activation

In case of the EGF/EGFR, NADPH oxidases may only play a role in transactivation of the receptor (Figure 5.1) [57,58]. For its endosomal signaling, quiescin sulfhydryl oxidase 1 (QSOX1) has been identified as a cellular pro-oxidant, which accelerates ubiquitination-mediated degradation of EGFR and its intracellular endosomal trafficking in hepatocellular carcinoma (HCC) cells [59]. The longer version of human QSOX1 protein (hQSOX1a) is a transmembrane protein localized primarily to the Golgi apparatus [60], while QSOX1b lacks the transmembrane helix and therefore is soluble, secreted and accumulates in extracellular fluids [61]. Importantly, the enzyme produces hydrogen peroxide that can reduce thiols in proteins and forms disulfides. Another reactive oxygen species is superoxide anion (•O2ˉ). It was suggested that •O2ˉ and Clˉ are transported through DIDS-sensitive chloride channel(s) out of early endosomes, where •O2ˉ is converted into H2O2 by superoxide dismutase (SOD1). H2O2 then enables further signaling outside of the endosome [62]. Such mechanism would define endosomes as internal sources of ROS, and suggests •O2ˉ-formation to occur within endosomes. Both cellular and endosomal ROS activate c-Src and Matrix-Metalloproteases (MMP) followed by ligand shedding of EGFR ligands. This EGFR trans-activation leads as a feed forward mechanism to further ROS creation by Nox. As a result, specific signals are generated for proliferation, neointima formation etc. [63,64]
Together, the data indicate a role of H2O2 at least in early endosome signaling, which is terminated by a pH dependent feedback mechanism in the course of endosome progression.

4. Conclusions

Early endosomes are a compartment for fine-tuned sorting and diverse fates that a cargo can be dictated to. The discovery of redoxosomes has added another layer of complexity to the concept of early endosomes as active signaling components. Further research is needed especially when it comes to EGFR signaling via the endosomal compartment as trafficking deficient EGFR mutants harbor oncogenic features [65], which underlines the therapeutic potential of intervening with endosomal sorting.

Funding

none.

Acknowledgments

No other collaborators.

Conflicts of Interest

None.

Abbreviations

APPL adapter protein containing PH domain, PTB domain and leucine zipper motif 1,2
CD Cluster of differentiation
CIN85 Cbl-interacting protein
CLC-3 Cloride channel 3 protein
DUB Deubiquitinating enzyme
EEA Early endosome antigen
EGF(R) Epidermal Growth Factor (Receptor)
Eps15 Epidermal Growth Factor Receptor Substrate 15
ER Endoplasmic Reticulum
Grb-2 Growth Factor Receptor-Bound Protein 2
HRP Horseradish peroxidase 1
Hrs Hepatocyte growth factor-regulated tyrosine kinase substrate
LAMP1 Lysosome associated membrane protein 1
LPA Lysophosphatidic acid
MTM1 Myotubularin 1
Nox NADPH oxidase
PIK phosphoinositide kinase
PtdIns Phosphatidylinositol
PTP1B Phosphotyrosine phosphatase 1
Rab(IP) Ras-related protein (Interacting protein)
Rabaptin Rab GTPase-binding effector protein
ROS Reactive Oxygen species
SNARE Soluble N-ethylmaleimide-sensitive factor attachment protein receptor
SNX Sorting Nexin
SOD Superoxide dismutase
STAM Signal Transducing Adaptor Molecule
TGF Transforming growth factor
TNF Tumor Necrosis Factor
Tsg101 Tumor susceptibility gene 101
Ub Ubiquitin
*Abbreviations in figures are explained in the figure legend.

References

  1. Steinman, R.M., Mellman, I.S., Muller, W.A.; Cohn, Z.A. Endocytosis and the recycling of plasma membrane. Journal of Cell Biology 1983, 96, 1–27. [CrossRef] [PubMed]
  2. Gruenberg, J. The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol 2001, 2, 721–730. [Google Scholar] [CrossRef] [PubMed]
  3. Kumari, S. , MG, S.; Mayor, S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res 2010, 20, 256–275. [Google Scholar] [CrossRef] [PubMed]
  4. Jovic, M. , Sharma, M., Rahajeng, J.; Caplan, S. The early endosome: a busy sorting station for proteins at the crossroads. Histology and histopathology 2010, 25, 99–112. [Google Scholar] [CrossRef]
  5. Naslavsky, N.; Caplan, S. The enigmatic endosome - sorting the ins and outs of endocytic trafficking. Journal of Cell Science. [CrossRef]
  6. Huotari, J.; Helenius, A. Endosome maturation. The EMBO Journal 2011, 30, 3481–3500. [Google Scholar] [CrossRef]
  7. Kamentseva, R.; et al. Functional cycle of EEA1-positive early endosome: Direct evidence for pre-existing compartment of degradative pathway. PLoS ONE 2020, 15, 0232532. [Google Scholar] [CrossRef]
  8. Griffiths, G.; Gruenberg, J. The arguments for pre-existing early and late endosomes. Trends in Cell Biology 1991, 1, 5–9. [Google Scholar] [CrossRef] [PubMed]
  9. Dunn, K.W.; Maxfield, F.R. Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes. Journal of Cell Biology 1992, 117, 301–310. [Google Scholar] [CrossRef]
  10. Sadowski, L. , Pilecka, I.; Miaczynska, M. Signaling from endosomes: location makes a difference. Experimental cell research 2009, 315, 1601–1609. [Google Scholar] [CrossRef]
  11. Scita, G.; Di Fiore, P.P. The endocytic matrix. Nature 2010, 463, 464–473. [Google Scholar] [CrossRef]
  12. Carpenter, G.; Cohen, S. Epidermal growth factor. Annual review of biochemistry 1979, 48, 193–216. [Google Scholar] [CrossRef] [PubMed]
  13. Roskoski, R. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacological Research 2014, 79, 34–74. [Google Scholar] [CrossRef] [PubMed]
  14. Tomas, A. , Futter, C.E.; Eden, E.R. EGF receptor trafficking: consequences for signaling and cancer. Trends in Cell Biology 2014, 24, 26–34. [Google Scholar] [CrossRef] [PubMed]
  15. Stoorvogel, W. , Strous, G.J., Geuze, H.J., Oorschot, V.; Schwartzt, A.L. Late endosomes derive from early endosomes by maturation. Cell 1991, 65, 417–427. [Google Scholar] [CrossRef] [PubMed]
  16. Mellman, I. Endocytosis and molecular sorting. Annual review of cell and developmental biology 1996, 12, 575–625. [Google Scholar] [CrossRef]
  17. Dammai, V. Endosomal Compartments. In Encyclopedia of cancer, edited by M. Schwab (Springer, Berlin, Heidelberg, 2011), pp. 1244–1248.
  18. Ferguson, S.M.; Camilli, P. de. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol 2012, 13, 75–88. [Google Scholar] [CrossRef]
  19. Lakadamyali, M. , Rust, M.J.; Zhuang, X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006, 124, 997–1009. [Google Scholar] [CrossRef]
  20. Roepstorff, K. , Grøvdal, L., Grandal, M., Lerdrup, M.; van Deurs, B. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem Cell Biol 2008, 129, 563–578. [Google Scholar] [CrossRef]
  21. Bertelsen, V.; Stang, E. The Mysterious Ways of ErbB2/HER2 Trafficking. Membranes 2014, 4, 424–446. [Google Scholar] [CrossRef]
  22. Barral, D.C.; et al. Current methods to analyze lysosome morphology, positioning, motility and function. Traffic (Copenhagen, Denmark) 2022, 23, 238–269. [Google Scholar] [CrossRef]
  23. Forgac, M. Structure and properties of the coated vesicle proton pump. Annals of the New York Academy of Sciences 1992, 671, 273–283. [Google Scholar] [CrossRef] [PubMed]
  24. Hara-Chikuma, M.; et al. ClC-3 Chloride Channels Facilitate Endosomal Acidification and Chloride Accumulation. Journal of Biological Chemistry 2005, 280, 1241–1247. [Google Scholar] [CrossRef] [PubMed]
  25. Stein, M.-P. , Dong, J.; Wandinger-Ness, A. Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. Advanced drug delivery reviews 2003, 55, 1421–1437. [Google Scholar] [CrossRef] [PubMed]
  26. Tan, X. , Lambert, P.F., Rapraeger, A.C.; Anderson, R.A. Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications. Trends in Cell Biology 2016, 26, 352–366. [Google Scholar] [CrossRef] [PubMed]
  27. Roepstorff, K.; et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic (Copenhagen, Denmark) 2009, 10, 1115–1127. [Google Scholar] [CrossRef]
  28. Schroeder, B. , Srivatsan, S., Shaw, A., Billadeau, D.; McNiven, M.A. CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies. MBoC 2012, 23, 3602–3611. [Google Scholar] [CrossRef]
  29. Levkowitz, G.; et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes & development 1998, 12, 3663–3674. [Google Scholar] [CrossRef]
  30. van Bergen En Henegouwen, P.M. Eps15: a multifunctional adaptor protein regulating intracellular trafficking. Cell communication and signaling : CCS 2009, 7, 24. [Google Scholar] [CrossRef]
  31. Fraser, J.; et al. Targeting of early endosomes by autophagy facilitates EGFR recycling and signalling. EMBO Rep. [CrossRef]
  32. Herbst, J.J. , Opresko, L.K., Walsh, B.J., Lauffenburger, D.A.; Wiley, H.S. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. Journal of Biological Chemistry 1994, 269, 12865–12873. [Google Scholar] [CrossRef]
  33. Rink, J. , Ghigo, E., Kalaidzidis, Y.; Zerial, M. Rab Conversion as a Mechanism of Progression from Early to Late Endosomes. Cell 2005, 122, 735–749. [Google Scholar] [CrossRef]
  34. Willingham, M.C.; Pastan, I. The receptosome: an intermediate organelle of receptor mediated endocytosis in cultured fibroblasts. Cell 1980, 21, 67–77. [Google Scholar] [CrossRef] [PubMed]
  35. Futter, C.E. , Pearse, A., Hewlett, L.J.; Hopkins, C.R. Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. Journal of Cell Biology 1996, 132, 1011–1023. [Google Scholar] [CrossRef] [PubMed]
  36. Bi, X.; et al. Tagging Transferrin Receptor with a Disulfide FRET Probe To Gauge the Redox State in Endosomal Compartments. Analytical chemistry 2020, 92, 12460–12466. [Google Scholar] [CrossRef] [PubMed]
  37. Shahin, W.S.; Engelhardt, J.F. Isolation of Redox-Active Endosomes (Redoxosomes) and Assessment of NOX Activity. Methods in molecular biology (Clifton, N.J.) 2019, 1982, 461–472. [Google Scholar] [CrossRef]
  38. Löwe, O.; et al. BIAM switch assay coupled to mass spectrometry identifies novel redox targets of NADPH oxidase 4. Redox Biology 2019, 21, 101125. [Google Scholar] [CrossRef]
  39. Pillay, C.S. , Elliott, E.; Dennison, C. Endolysosomal proteolysis and its regulation. The Biochemical journal 2002, 363, 417–429. [Google Scholar] [CrossRef]
  40. Collins, D.S. , Unanue, E.R.; Harding, C.V. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. Journal of immunology (Baltimore, Md. : 1950) 1991, 147, 4054–4059. [Google Scholar] [CrossRef]
  41. Austin, C.D.; et al. Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates. Proceedings of the National Academy of Sciences of the United States of America 2005, 102, 17987–17992. [Google Scholar] [CrossRef]
  42. Dingjan, I.; et al. Oxidized phagosomal NOX2 complex is replenished from lysosomes. Journal of Cell Science 2017, 130, 1285–1298. [Google Scholar] [CrossRef]
  43. Schröder, K. , Weissmann, N.; Brandes, R.P. Organizers and activators: Cytosolic Nox proteins impacting on vascular function. Free Radical Biology and Medicine 2017, 109, 22–32. [Google Scholar] [CrossRef]
  44. Spencer, N.Y.; Engelhardt, J.F. The Basic Biology of Redoxosomes in Cytokine-Mediated Signal Transduction and Implications for Disease-Specific Therapies. Biochemistry 2014, 53, 1551–1564. [Google Scholar] [CrossRef] [PubMed]
  45. Oakley, F.D. , Abbott, D., Li, Q.; Engelhardt, J.F. Signaling Components of Redox Active Endosomes: The Redoxosomes. Antioxidants & Redox Signaling 2009, 11, 1313–1333. [Google Scholar] [CrossRef]
  46. Schröder, K. NADPH oxidases: Current aspects and tools. Redox Biology 2020, 34, 101512. [Google Scholar] [CrossRef] [PubMed]
  47. Moghadam, Z.M. , Henneke, P.; Kolter, J. From Flies to Men: ROS and the NADPH Oxidase in Phagocytes. Frontiers in cell and developmental biology 2021, 9, 628991. [Google Scholar] [CrossRef] [PubMed]
  48. Ewanchuk, B.W.; Yates, R.M. The phagosome and redox control of antigen processing. Free radical biology & medicine 2018, 125, 53–61. [Google Scholar] [CrossRef]
  49. Klomsiri, C.; et al. Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling. Free radical biology & medicine 2014, 71, 49–60. [Google Scholar] [CrossRef]
  50. Li, Q.; et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Molecular and cellular biology 2006, 26, 140–154. [Google Scholar] [CrossRef]
  51. Fisher, A.B. Redox signaling across cell membranes. Antioxidants & Redox Signaling 2009, 11, 1349–1356. [Google Scholar] [CrossRef]
  52. Miller, F.J.; et al. Cytokine Activation of Nuclear Factor κB in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3. Circulation Research 2007, 101, 663–671. [Google Scholar] [CrossRef]
  53. Chu, Y.; et al. Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparin-binding domain. ATVB 2006, 26, 1985–1990. [Google Scholar] [CrossRef]
  54. Wang, W.; et al. Superoxide dismutase transcellular shuttle constructed from dendritic MOF and charge reversible protein derivatives. Chemical science 2019, 10, 4476–4485. [Google Scholar] [CrossRef] [PubMed]
  55. Helmcke, I. , Heumüller, S., Tikkanen, R., Schröder, K.; Brandes, R.P. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxidants & Redox Signaling 2009, 11, 1279–1287. [Google Scholar] [CrossRef]
  56. Park, D.-R. , Nam, T.-S., Kim, Y.-W., Bae, Y.S.; Kim, U.-H. Oxidative activation of type III CD38 by NADPH oxidase-derived hydrogen peroxide in Ca2+ signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2019, 33, 3404–3419. [Google Scholar] [CrossRef]
  57. Heppner, D.E.; et al. The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling. Journal of Biological Chemistry 2016, 291, 23282–23293. [Google Scholar] [CrossRef]
  58. Forrester, S.J.; et al. Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System. Annu. Rev. Pharmacol. Toxicol. 2016, 56, 627–653. [Google Scholar] [CrossRef]
  59. Sun, J.; et al. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation. Redox Biology 2021, 41, 101942. [Google Scholar] [CrossRef]
  60. Chakravarthi, S. , Jessop, C.E., Willer, M., Stirling, C.J.; Bulleid, N.J. Intracellular catalysis of disulfide bond formation by the human sulfhydryl oxidase, QSOX1. The Biochemical journal 2007, 404, 403–411. [Google Scholar] [CrossRef]
  61. Kodali, V.K.; Thorpe, C. Oxidative protein folding and the Quiescin-sulfhydryl oxidase family of flavoproteins. Antioxidants & Redox Signaling 2010, 13, 1217–1230. [Google Scholar] [CrossRef]
  62. Mumbengegwi, D.R. , Li, Q., Li, C., Bear, C.E.; Engelhardt, J.F. Evidence for a superoxide permeability pathway in endosomal membranes. Molecular and cellular biology 2008, 28, 3700–3712. [Google Scholar] [CrossRef]
  63. Moody, T.W. , Nuche-Berenguer, B., Nakamura, T.; Jensen, R.T. EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer. Current drug targets 2016, 17, 520–528. [Google Scholar] [CrossRef]
  64. Gianni, D. , Bohl, B., Courtneidge, S.A.; Bokoch, G.M. The Involvement of the Tyrosine Kinase c-Src in the Regulation of Reactive Oxygen Species Generation Mediated by NADPH Oxidase-1. MBoC 2008, 19, 2984–2994. [Google Scholar] [CrossRef] [PubMed]
  65. Arteaga, C.L.; Engelman, J.A. ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics. Cancer Cell 2014, 25, 282–303. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Overview of major endosomal subtypes and their charactericstic features. Nox=NADPH oxidase, ROS= Reacitve oxygen species , SARA=Smad anchor for receptor activation.
Figure 1. Overview of major endosomal subtypes and their charactericstic features. Nox=NADPH oxidase, ROS= Reacitve oxygen species , SARA=Smad anchor for receptor activation.
Preprints 119140 g001
Figure 2. Structure of the early endosome. Early endosomes display a dynamic, pleiomorphic appearance with a cis site for incoming cargo and a trans region with tubular and multivesicular structures which differ in their pH according to the destination of cargo either for recycling or degradation. The most important Rab proteins and exemplarily one of their effectors are displayed. Cargo exits the early endosome for further intracellular trafficking. Early endosomes are connected to both the microtubule organizing centre (MTOC) of the cytoskeleton through annexins and to several motor proteins which allows movement of Early endosomes themselves and cargo delivery. The endosomal pH gradient is indicated by color. ACAP2= ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, APPL= Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1, EEA1=Early endosomal antigen 1, CRIM1= Cysteine-rich motor neuron 1, MICALL= Mical-like protein , OCRL= Inositol polyphosphate 5-phosphatase, Rab= Ras-related protein, RUFY1= RUN and FYVE domain-containing protein 1.
Figure 2. Structure of the early endosome. Early endosomes display a dynamic, pleiomorphic appearance with a cis site for incoming cargo and a trans region with tubular and multivesicular structures which differ in their pH according to the destination of cargo either for recycling or degradation. The most important Rab proteins and exemplarily one of their effectors are displayed. Cargo exits the early endosome for further intracellular trafficking. Early endosomes are connected to both the microtubule organizing centre (MTOC) of the cytoskeleton through annexins and to several motor proteins which allows movement of Early endosomes themselves and cargo delivery. The endosomal pH gradient is indicated by color. ACAP2= ArfGAP with coiled-coil, ankyrin repeat and PH domains 2, APPL= Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1, EEA1=Early endosomal antigen 1, CRIM1= Cysteine-rich motor neuron 1, MICALL= Mical-like protein , OCRL= Inositol polyphosphate 5-phosphatase, Rab= Ras-related protein, RUFY1= RUN and FYVE domain-containing protein 1.
Preprints 119140 g002
Figure 3. Dynamics and maturation of endosomes. Exemplarily, endocytosis of a dimeric receptor after ligand binding is shown. At early endosomes, the receptor is sorted for recycling or degradation and travels through the endosomal network. Key marker proteins of endsomal compartments are indicated. EEA1=Early endosome antigen 1, Rab=Ras-related protein, Lamp1=Lysosomal associated membrane protein 1.
Figure 3. Dynamics and maturation of endosomes. Exemplarily, endocytosis of a dimeric receptor after ligand binding is shown. At early endosomes, the receptor is sorted for recycling or degradation and travels through the endosomal network. Key marker proteins of endsomal compartments are indicated. EEA1=Early endosome antigen 1, Rab=Ras-related protein, Lamp1=Lysosomal associated membrane protein 1.
Preprints 119140 g003
Figure 4. EGF and MG8 receptor trafficking in detail. Clathrin-mediated endocytosis of EGFR and intracellular trafficking of M6RR are shown. EGFR may be translocated to other cellular compartments like nucleoplasm or mitochondria (not shown). No claim to completeness of molecules showed. 1) Recruting of major adaptor proteins to EGFR during internalization. The activated receptor dimers are internalized by various pathways depending on ligand type and concentration. The adapter protein Grb2 recruits the ubiquitin ligase Cbl to EGFR causing mono- or polyubiquitination. Multiple Ub-binding proteins interact with the ubiquitinated EGFR 2) Association of recycling machinery. Association of Rab4,11,13,35 leads to direct or indirect recycling via the endosomal recycling complex. Deubiquitinating enzymes replenish the free Ub pool. 3) Lysosomal targeting of EGFR. Dephosphorylation of EGF receptor tyrosine kinases by PTPs terminates signaling and promotes formation of intraluminal vesicles / multivesicular bodies. EGFR interaction with Hrs and recruitment of ESCRT complex is necessary for the late endosomal-lysosomal route. AMSH=Associated Molecule with the SH3 domain of STAM, Cbl=Casitas B-lineage Lymphoma protein, CIN-85=Cbl-interacting protein, Eps= Epidermal Growth Factor Receptor Substrate 15, ESCRT=Endosomal Sorting Complex Required for Transport, Hrs=Hepatocyte Growth Factor- Regulated Tyrosine Kinase, PTP1B=Phosphotyrosinephosphatase 1 B, SNX= Sorting Nexin, STAM=Signal Transducing Adaptor Molecule Substrate, Tsg101=Tumor Susceptibility Gene 101, Ub=Ubiquitin,WASH= Wiskott-Aldrich syndrome protein and SCAR homolog.
Figure 4. EGF and MG8 receptor trafficking in detail. Clathrin-mediated endocytosis of EGFR and intracellular trafficking of M6RR are shown. EGFR may be translocated to other cellular compartments like nucleoplasm or mitochondria (not shown). No claim to completeness of molecules showed. 1) Recruting of major adaptor proteins to EGFR during internalization. The activated receptor dimers are internalized by various pathways depending on ligand type and concentration. The adapter protein Grb2 recruits the ubiquitin ligase Cbl to EGFR causing mono- or polyubiquitination. Multiple Ub-binding proteins interact with the ubiquitinated EGFR 2) Association of recycling machinery. Association of Rab4,11,13,35 leads to direct or indirect recycling via the endosomal recycling complex. Deubiquitinating enzymes replenish the free Ub pool. 3) Lysosomal targeting of EGFR. Dephosphorylation of EGF receptor tyrosine kinases by PTPs terminates signaling and promotes formation of intraluminal vesicles / multivesicular bodies. EGFR interaction with Hrs and recruitment of ESCRT complex is necessary for the late endosomal-lysosomal route. AMSH=Associated Molecule with the SH3 domain of STAM, Cbl=Casitas B-lineage Lymphoma protein, CIN-85=Cbl-interacting protein, Eps= Epidermal Growth Factor Receptor Substrate 15, ESCRT=Endosomal Sorting Complex Required for Transport, Hrs=Hepatocyte Growth Factor- Regulated Tyrosine Kinase, PTP1B=Phosphotyrosinephosphatase 1 B, SNX= Sorting Nexin, STAM=Signal Transducing Adaptor Molecule Substrate, Tsg101=Tumor Susceptibility Gene 101, Ub=Ubiquitin,WASH= Wiskott-Aldrich syndrome protein and SCAR homolog.
Preprints 119140 g004
Figure 5. ROS in endosomal sorting and signaling. Redox signaling is initiated by EGFR 1) at the plasma membrane 2) inside of endosomes. Redox-active endosomes (Redoxosomes) harbor Nox enzymes producing ROS downstream of several signaling cascades. Both cellular and endosomal ROS activate c-Src and MMPs followed by shedding of EGFR ligands. This EGFR trans-activation leads as a feed forward mechanism to further ROS creation by Nox. Termination of the ROS signaling by dismutation or other means is not shown. Clc3 provides charge neutralization. Clc3= Cloride channel 3, cSrc= cellular Sarcoma kinase, EGFR=Epidermal Growth Factor Receptor, IL1R=Interleukin 1 receptor, MMP= Matrixmetalloprotease, Nox= NADPH oxidase, ROS=Reactive oxygen species, TNFR=Tumor necrosis factor receptor.
Figure 5. ROS in endosomal sorting and signaling. Redox signaling is initiated by EGFR 1) at the plasma membrane 2) inside of endosomes. Redox-active endosomes (Redoxosomes) harbor Nox enzymes producing ROS downstream of several signaling cascades. Both cellular and endosomal ROS activate c-Src and MMPs followed by shedding of EGFR ligands. This EGFR trans-activation leads as a feed forward mechanism to further ROS creation by Nox. Termination of the ROS signaling by dismutation or other means is not shown. Clc3 provides charge neutralization. Clc3= Cloride channel 3, cSrc= cellular Sarcoma kinase, EGFR=Epidermal Growth Factor Receptor, IL1R=Interleukin 1 receptor, MMP= Matrixmetalloprotease, Nox= NADPH oxidase, ROS=Reactive oxygen species, TNFR=Tumor necrosis factor receptor.
Preprints 119140 g005
Table 1. Classification of receptor mediated signaling.
Table 1. Classification of receptor mediated signaling.
Type I signaling: Ligand binding to the receptor results in direct signal transduction e.g. Tyrosinkinase receptors
Type II signaling Upon binding of the ligand, second messengers mediate signal transduction e.g. Adrenalin β-receptors
Type III signaling Binding of the ligand to its receptor induces internalization and formation of endosomes, which transduced the appropriate signaling cascade e.g. EGF-receptor
IIIA recruitment of cytosolic proteins to the receptor, followed by internalization and endosome formation e.g. EGF- and TGFβ-receptors
IIIB Fusion of the endosome with other intracellular vesicles e.g. TNFα-receptor fuses with the Golgi to transduce apoptosis signals
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated